- Home
- ROIV vs PKG Comparison
ROIV vs PKG Comparison
Compare ROIV & PKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | PKG |
|---|---|---|
| Founded | 2014 | 1867 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 17.4B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | ROIV | PKG |
|---|---|---|
| Price | $26.32 | $245.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $27.44 | ★ $238.00 |
| AVG Volume (30 Days) | ★ 6.9M | 1.2M |
| Earning Date | 02-06-2026 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.03% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 8.58 |
| Revenue | $13,310,000.00 | ★ $8,989,300,000.00 |
| Revenue This Year | N/A | $13.00 |
| Revenue Next Year | $741.42 | $4.70 |
| P/E Ratio | ★ N/A | $28.70 |
| Revenue Growth | N/A | ★ 7.23 |
| 52 Week Low | $8.73 | $172.72 |
| 52 Week High | $27.94 | $249.51 |
Technical Indicators
Market Signals| Indicator | ROIV | PKG |
|---|---|---|
| Relative Strength Index (RSI) | 66.81 | 77.01 |
| Support Level | $26.31 | $215.47 |
| Resistance Level | $27.94 | $249.51 |
| Average True Range (ATR) | 0.97 | 6.61 |
| MACD | 0.46 | 1.63 |
| Stochastic Oscillator | 79.45 | 88.31 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PKG Packaging Corporation of America
Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.